The Broad strives to build deep, long-lasting, collaborative relationships with exceptional partners, ranging from broad-based research and technology collaborations to joint drug discovery programs. Our unique institutional structure enables partnerships to span multiple investigators and novel platform technologies across diverse areas of expertise.  Our foundation in genetics empowers us to systematically identify genes associated with human disease, and we have tools to transform genomic information into an understanding of molecular pathways.

Our technologies for manipulating genomes and cellular circuits—and for analyzing large datasets—help identify and characterize molecular targets and formulate therapeutic hypotheses. We also have powerful new chemical, biological and drug discovery technologies to identify molecules that modulate pathways and generate novel therapeutic candidates. 

The Broad welcomes opportunities to explore new strategic partnerships and new ventures in key areas of scientific interest including genetics, biology, drug discovery, and technology.

Office of Strategic Alliances and Partnering